Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

Can immune system rejuvenation restore age-related memory loss?

IMMUNE/MEMORY AGING

With increased life expectancy, there has been a critical growth in the portion of the population that suffers from age-related cognitive decline and dementia. Attempts are therefore being made to find ways to slow brain-aging processes; successful therapies would have a significant impact on the quality of life of individuals, and decrease...

Funding Programme
Start Date
End Date
Total Funding
€ 1 650 000
European Countries Involved

CARELINK for People with Dementia and their community

CARE-LINK

The objective of CARELINK is to deliver a tracking solution that addresses the issue of wandering in People with Dementia (PwD), allowing carers to monitor PwD. Using current machine-learning technologies we will profile user routes that can then be used to build a repository of route patterns to be compared against live routes, thus allowing for...

Funding Programme
Start Date
End Date
Total Funding
€ 2 282 944
European Countries Involved

Cell type-specific molecular analysis of epigenetic changes and transposable element derepression in Alzheimer's disease progression

CTS-TEs-ADprogress

Alzheimer’s disease (AD) is a major contributor to disease burden and healthcare costs worldwide. AD is usually diagnosed once symptoms like memory impairment become evident. However, at this point typical AD pathology such as Aβ plaques and cell death is already widespread, suggesting that molecular changes have occurred decades before symptom...

Funding Programme
Start Date
End Date
Total Funding
€ 174 806
European Countries Involved

Cellular determinants of neuronal plasticity
on the level of single synapses in vivo

InVivoSynapse

The search for the fundamental mechanisms of learning and experience-dependent memory formation in the brain has long been a central quest in neuroscience. The neocortex is a particularly relevant region for plasticity because it is involved in sensory, motor, and cognitive tasks with strong learning components. However, despite many years of...

Funding Programme
Start Date
End Date
Total Funding
€ 2 404 800
European Countries Involved

Cellular Strategies of Protein Quality Control-Degradation

CellularPQCD

Maintaining the quality of all proteins in an organism is fundamental to life since it ensures tissue function, organismal health, and longevity. Protein quality control (PQC) is achieved by selective degradation of damaged proteins, limiting the formation of protein aggregates and neurodegeneration characteristic of Alzheimers, Huntingtons, and...

Funding Programme
Start Date
End Date
Total Funding
€ 2 500 000
European Countries Involved

Center for Artificial Intelligence and Quantum Computing in System Brain Research

CLARA

CLARA, the Center for Artificial Intelligence and Quantum Computing in System Brain Research, represents the interdisciplinary center of excellence focused on the next generation of artificial intelligence/machine learning applications and quantum-centric supercomputing tools to push the frontier of neurodegeneration research, particularly...

Funding Programme
Start Date
End Date
Total Funding
€ 14 999 782
European Countries Involved

Chair of Neuroinformatics

CONI

Neuroinformatics (NI) is now an essential approach in brain research, to organise, analyse, integrate and interpret an increasing volume of diverse, multi-dimensional, fine-grain neuroscience data. University of Ljubljana's (UL's) challenges in this field are suboptimal research management & open innovation (OI), slow pace of structural changes...

Funding Programme
Start Date
End Date
Total Funding
€ 2 499 996
European Countries Involved

Characterising protein oligomers and their role in neurodegenerative disease in humans

Oligomers

Small soluble protein aggregates play a key role in the onset and spreading of Alzheimer’s and Parkinson’s diseases. However, which oligomers are present in human disease and which are toxic remains unknown because ultrasensitive methods do not exist to detect and characterise the low concentration of oligomers, which are highly heterogeneous in...

Funding Programme
Start Date
End Date
Total Funding
€ 2 499 551
European Countries Involved

Characterising protein oligomers and their role in neurodegenerative disease in humans

Oligomers

Small soluble protein aggregates play a key role in the onset and spreading of Alzheimer’s and Parkinson’s diseases. However, which oligomers are present in human disease and which are toxic remains unknown because ultrasensitive methods do not exist to detect and characterise the low concentration of oligomers, which are highly heterogeneous...

Funding Programme
Start Date
End Date
Total Funding
€ 2 499 551
European Countries Involved

Characterization of the role of Sac1 in the spatiotemporally controlled interplay between PI4P and cholesterol homeostasis

PIP-AID

Lipids are essential components of cell membranes. Every organelle membrane is constituted of a unique composition of different lipid species. This distinctive lipid distribution along organelle membranes is important to maintain the identity and functions of the different organelles. In this research project, I aim to understand how the lipid...

Funding Programme
Start Date
End Date
Total Funding
€ 199 694
European Countries Involved

Circadian rhythm: from preclinical to post-diagnosis dementia

RHYTHM IN DEMENTIA

Circadian rhythm (CR) regulates body functions over the 24-hour day/night period; sleep/wake cycle is its most visible manifestation. CR disruptions have long been observed in patients with dementia and emerging evidence points to their presence in the preclinical period of dementia. This suggests that certain aspects of CR could be useful in...

Funding Programme
Start Date
End Date
Total Funding
€ 1 999 982
European Countries Involved

Closed-loop deep learning in early-stage drug discovery - cloud platform for targeted protein degradation

CelerisTx - Celeris One Platform

Celeris Therapeutics is a deep learning company that uses innovative, in-silico methods such as geometric deep learning and graph neural networks to degrade currently undruggable targets (pathogenic proteins). The platform shall make a broad impact by addressing currently incureable diseases such as Alzheimer's, Parkinson's, and different types of...

Funding Programme
Start Date
End Date
Total Funding
€ 2 500 000
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).